Building on its Alabama Drug Development Alliance and years of close collaboration, Southern Research and UAB launched the AIMTech venture to develop new medical devices to improve healthcare in the U.S. and around the world.
The strategic partnership combines the research and discovery expertise of Southern Research scientists and engineers and UAB biomedical engineers and clinicians. AIMTech seeks to create medical devices across five specializations: cardiology, orthopedics, ophthalmology, rehabilitative engineering, and trauma.
“Partnering with UAB on this initiative allows us to accelerate commercialization of medical technologies, improve healthcare delivery and outcomes, and generate economic development and growth,” Southern Research President and CEO Dr. Art Tipton said. “This is also an opportunity to develop a lucrative business unit that will potentially create a number of new companies and jobs within the rapidly-growing biomedical engineering industry.”
AIMTech seeks to invent the new medical devices, help raise venture capital, establish small medical device companies, and manage the clinical trial and FDA approval processes. Major medical device companies will manufacture and sell the devices.